Dexcom Q2 Adjusted EPS USD 0.7 Vs. IBES Estimate USD 0.61
DXCM•Dexcom reports second-quarter results above estimates
Jul 30 (Reuters) - Dexcom Q2 revenue was USD 1,308 million versus the IBES estimate of USD 1,290 million.
- Q2 adjusted EPS: USD 0.7 vs. IBES estimate of USD 0.61
- Q2 adjusted operating income: USD 328.3 million vs. IBES estimate of USD 285.5 million
- Q2 adjusted gross profit: USD 838.5 million
- Q2 operating income: USD 318.3 million
- Q2 adjusted net income: USD 269.1 million vs. IBES estimate of USD 235.8 million
- Q2 gross profit: USD 830 million




